Skip to content

Author

K. Prasert

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.

BACKGROUND HXP-GPOVac is a Thailand-produced, egg-based, inactivated recombinant Newcastle disease virus (NDV)-chimera vaccine expressing a membrane-anchored, prefusion-stabilized SARS-CoV-2 spike (NDV-HXP-S), developed to expand vaccine access. This phase III trial evaluated the safety and immunogenicity of a single H...

Kriengkrai Prasert, S. Nakphook, Jiraphut Kittiwatanachod et al. · 0 citations
Open access May 2026

Influenza Vaccine Effectiveness Against Pneumonia and COPD Exacerbations Among Patients with Chronic Obstructive Pulmonary Disease in Thailand: A National Test-Negative Design Study, 2013–2024

Background/Objectives: Influenza infection is a major trigger of pneumonia and acute exacerbations among patients with chronic obstructive pulmonary disease (COPD). However, national laboratory-confirmed evidence on influenza vaccine effectiveness (VE) in this high-risk population remains limited. This study aimed to e...

Sutthinan Chawalchitiporn, P. Tantiyavarong, Jiraphut Kittiwatanachod et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.